Evolve25: Fireside chat with Brian Martin From AbbVie

*Start your Free Trial:* https://www.cloudera.com/products/cloudera-public-cloud-trial.html
AbbVie Chief Architect Brian Martin joins Cloudera’s Abhas Ricky to reveal how the pharmaceutical giant is shifting from qualitative to quantitative R&D decision-making using AI.

Discover how AbbVie leverages Knowledge Graphs and RAG (Retrieval-Augmented Generation) to automate clinical study reports, reducing draft times by up to 80%. Learn about their "three-class formalism" for human-in-the-loop governance and how they achieved a 250,000-hour FTE return on investment in 2024.

This session provides a strategic roadmap for scaling AI in highly regulated industries while maintaining strict data security and clinical integrity.

Discover more from our Evolve25 events by subscribing to Cloudera! Full Playlist: https://www.youtube.com/playlist

Chapters:

00:00 Intro: Meet Brian Martin, Chief AI Architect at AbbVie

00:46 Three Pillars of Enterprise GenAI: Use Cases, Metrics, and Takeaways

01:32 Qualitative to Quantitative: How LLMs unlock R&D data value

02:20 The Pharmaceutical R&D Pipeline: From discovery to market access

03:07 Building Knowledge Graphs: Supplying quantitative evidence to medical experts

04:04 RAG and Graph Relationships: Powering the next generation of AI use cases

04:23 Automated Document Generation: Shrinking weeks of work into first drafts

04:54 Case Study: Accelerating FDA regulatory submissions with AI

05:46 Measuring Success: Operational, Analytical, and Experiential ROI

06:41 AI as a Team Sport: How to evaluate strategic technology partners

07:28 Curing Pilot-itis: Shifting from tech-driven to business-driven AI

08:28 Service Now Integration: Connecting configuration management and data lineage

09:20 Focus on Business Outcomes: Why AI is a talent arbitrage problem

10:16 Enterprise Metrics: How AbbVie returned 250,000 hours to employees

11:03 Hard vs. Soft KPIs: Differentiating value in automated help desk tickets

12:15 Strategic Guardrails: Defining the levels of AI governance

13:42 Formalizing Human-in-the-Loop (HITL): Three classes of evaluation

14:48 Evaluating outcomes: Active vs. Passive monitoring thresholds

15:21 Conclusion: The critical importance of AI guardrails

#EnterpriseAI #GenAI #AbbVie #Cloudera #DataGovernance #AIStrategy #GenerativeAI #KnowledgeGraph #PharmaTech #DigitalTransformation